CHF Solutions (NSDQ: CHFS) said yesterday it enacted a 1-for-20 reverse split of its common stock, putting 1 share in the hands of each shareholder for every 20 they previously owned. The move was approved at a special meeting of stockholders on Tuesday, the Eden Prairie, Minn.-based company said, with trading beginning on a split adjusted basis […]
Globus Medical (NYSE:GMED) said yesterday that it named David Demski as its new chief executive officer, effective immediately, replacing David Paul who is stepping down due to health issues but will stay on as executive chairman. Demski has served as a Globus senior executive since 2003 and operated as CFO from 2003 to 2008, moving to […]
A panel of regulatory experts convened at DeviceTalks Minnesota this year to chat with MassDevice.com editor Sarah Faulkner. The group of regulatory experts included Danelle Miller, VP of regulatory policy & intelligence at Roche Diagnostics; Megan Brandt, VP of regulatory affairs and quality assurance at CHF Solutions (NSDQ:CHFS); and Mac McKeen, regulatory science fellow at Boston Scientific (NYSE:BSX). Faulkner: We […]
CHF Solutions (NSDQ: CHFS), formerly known as Sunshine Heart, said today that researchers at Stanford University School of Medicine’s dept. of pediatrics won FDA investigational device exemption approval to initiate a study of its Aquadex FlexFlow aquapheresis system. The Aquadex FlexFlow is an aquapheresis system designed for diuretic-resistant fluid overload in children with decompensated heart […]
Sunshine Heart (NSDQ:SSH) said today it is rebranding under the moniker CHF Solutions. As part of the change, the company’s stock ticker will shift from SSH to CHFS, the Eden Prairie, Minn.-based company said, expected to take effect May 24. “We are pleased to align our corporate name and identity with our new commercial focus. CHF Solutions […]
By Thomas Lee
BROOKLYN PARK, Minnesota– CHF Solutions Inc. raised $1.8 million from investors, according to documents filed with the Securities and Exchange Commission.
The company is seeking a total of $2.3 million from the sale of equity.